Showing 1 - 10 results of 10 for search 'Yalai Bai', query time: 0.04s Refine Results
  1. 1
    Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method.

    Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method. by Yalai Bai, Huan Cheng, Jennifer Bordeaux, Veronique Neumeister, Sudha Kumar, David L Rimm, David F Stern

    Published 2013-01-01
    Get full text
    Article
  2. 2
    The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?Research in context

    The analytical and clinical validity of AI algorithms to score TILs in TNBC: can we use different machine learning models interchangeably?Research in context by Joan Martínez Vidal, Nikos Tsiknakis, Johan Staaf, Ana Bosch, Anna Ehinger, Emma Nimeus, Roberto Salgado, Yalai Bai, David L. Rimm, Johan Hartman, Balazs Acs

    Published 2024-12-01
    Get full text
    Article
  3. 3
    Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors

    Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors by Christina M. Dieli-Conwright, Maura Harrigan, Brenda Cartmel, Anees Chagpar, Yalai Bai, Fang-yong Li, David L. Rimm, Lajos Pusztai, Lingeng Lu, Tara Sanft, Melinda L. Irwin

    Published 2022-03-01
    Get full text
    Article
  4. 4
    Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study

    Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility stud... by Ioannis Zerdes, Michele Simonetti, Alexios Matikas, Luuk Harbers, Balazs Acs, Ceren Boyaci, Ning Zhang, Dimitrios Salgkamis, Susanne Agartz, Pablo Moreno-Ruiz, Yalai Bai, David L. Rimm, Johan Hartman, Artur Mezheyeuski, Jonas Bergh, Nicola Crosetto, Theodoros Foukakis

    Published 2021-11-01
    Get full text
    Article
  5. 5
    Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer

    Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer by Michal Marczyk, Tao Qing, Tess O’Meara, Vesal Yagahoobi, Vasiliki Pelekanou, Yalai Bai, Emily Reisenbichler, Kimberly S. Cole, Xiaotong Li, Vignesh Gunasekharan, Eiman Ibrahim, Kristina Fanucci, Wei Wei, David L. Rimm, Lajos Pusztai, Kim R. M. Blenman

    Published 2022-07-01
    Get full text
    Article
  6. 6
    Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial

    Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial by Ioannis Zerdes, Alexios Matikas, Artur Mezheyeuski, Georgios Manikis, Balazs Acs, Hemming Johansson, Ceren Boyaci, Caroline Boman, Coralie Poncet, Michail Ignatiadis, Yalai Bai, David L. Rimm, David Cameron, Hervé Bonnefoi, Jonas Bergh, Gaetan MacGrogan, Theodoros Foukakis

    Published 2025-03-01
    Get full text
    Article
  7. 7
    Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer

    Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer by Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michal Marczyk, Courtney Frederick, Trisha Burrello, Eiman Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L. Rimm, Lajos Pusztai

    Published 2021-02-01
    Get full text
    Article
  8. 8
    Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial

    Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial by Kristina A. Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A. Nahleh, Saba Shafi, Sneha Burela, William E. Barlow, Priyanka Sharma, Alastair M. Thompson, Andrew K. Godwin, David L. Rimm, Gabriel N. Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R. M. Blenman

    Published 2023-05-01
    Get full text
    Article
  9. 9
    Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer

    Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer by Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michal Marczyk, Courtney Frederick, Trisha Burrello, Eiman Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L. Rimm, Lajos Pusztai

    Published 2022-02-01
    Get full text
    Article
  10. 10
    Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms

    Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms by Thazin Nwe Aung, Saba Shafi, James S. Wilmott, Saeed Nourmohammadi, Ioannis Vathiotis, Niki Gavrielatou, Aileen Fernandez, Vesal Yaghoobi, Tobias Sinnberg, Teresa Amaral, Kristian Ikenberg, Kiarash Khosrotehrani, Iman Osman, Balazs Acs, Yalai Bai, Sandra Martinez-Morilla, Myrto Moutafi, John F. Thompson, Richard A. Scolyer, David L. Rimm

    Published 2022-08-01
    Get full text
    Article

Search Tools: